Rheumatology group launches registry to get COVID-19 data on rheumatic disease patients

SAN FRANCISCO – Today, the COVID-19 Global Rheumatology Alliance launched an international registry to help collect data that will be used to guide rheumatology clinicians and health professionals as they assess and treat rheumatic disease patients who are, or may become, infected with the SARS-CoV-2 virus that causes COVID-19. The registry will also evaluate the…

Bentham Science announces new multidisciplinary journal, ‘Current Chinese Science’

Bentham Science announces an important new multidisciplinary journal, Current Chinese Science. This will be the world’s largest journal with over 4,000 leading Chinese scientists involved on its editorial board. Current Chinese Science is a peer reviewed journal with over 70 sections headed by leading Chinese scientists as Co-Editors. The journal will cover important and emerging…

BIDMC launches clinical trials evaluating anti-viral drug remdesivir for COVID-19

Boston, Mass. – Physician-scientists at Beth Israel Deaconess Medical Center (BIDMC) are now enrolling patients in two clinical trials testing treatment options for COVID-19, the illness caused by the novel coronavirus. Two trials, led by infectious disease specialist Kathryn Stephenson, MD, MPH, will test the antiviral drug remdesivir for safety and efficacy against the respiratory…